GSK Gets FDA Approval for Cervical Cancer Vaccine in Girls and Young Women
Links shared publicly online about this topic
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine
drugs.com — “Cervarix (Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant) is used for prevention of cervical cancer. Includes Cervarix side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 16, 2009 at 10:45 pm By:
FDA approves Cervarix, GlaxoSmithKline's cervical cancer vaccine - http://bit.ly/2Y6rH0
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine | Reuters
reuters.com — “PHILADELPHIA, Oct. 16 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX [Human papillomavirus bivalent (types” View full resource at reuters.com
Most Recently Shared on October 16, 2009 at 4:16 pm By:
Skin & Allergy News Health News
RT @Apfeiffer: RT @cancercures: FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine http://bit.ly/3PBG9D
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
Skin & Allergy News
The leading independent newspaper for medical, surgical, and aesthetic dermatology.
Advertisement
